Calciphylaxis: Treatment and outlook—CME part II-Reference-Cited by-同舟云学术

Calciphylaxis: Treatment and outlook—CME part II

Published:2022-05 Issue:5 Volume:86 Page:985-992
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Rick Jonathan,Rrapi Renajd,Chand Sidharth,Shinohara Michi M.,Strowd Lindsay,Pasieka Helena B.,Micheletti Robert,Kroshinsky Daniela,Ortega-Loayza Alex G.

Publisher

Elsevier BV

Subject

Dermatology

Reference63 articles.

1. Calciphylaxis: diagnosis and clinical features;Hayashi;Clin Exp Nephrol,2013

2. Calciphylaxis: natural history, risk factor analysis, and outcome;Weenig;J Am Acad Dermatol,2007

3. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update;Am J Kidney Dis,2015

4. Clinical characteristics and risk factors associated with mortality in calcific uremic arteriolopathy;Santos;Int Urol Nephrol,2017

5. Calcific uremic arteriolopathy in end stage renal disease: pathophysiology and management;Yerram;Ochsner J,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approach to the Atypical Wound;American Journal of Clinical Dermatology;2024-05-14

2. Calciphylaxis: complexity from presentation to treatment;Journal of Dermatology for Physician Assistants;2024-01

3. A retrospective review of outcomes after hyperbaric oxygen therapy for the treatment of calciphylaxis;Journal of the American Academy of Dermatology;2024-01

4. Calciphylaxis with primary hyperparathyroidism relieved by sodium thiosulfate and dialysis induction;Journal of the Japan Organization of Clinical Dermatologists;2024

5. Calciphylaxis: An Unusual and Silent Usher for an Underlying Carcinoma;Cureus;2023-11-06